These data suggest that FABP4 increases insulin secretion from pancreatic β-cells during obesity, as an adaptive β-cell response with adiposity, suggesting that FABP4 is a detectable proinflammatory biomarker that can mirror adiposity and obesity. This evidence concerns the gene FABP4 and obesity disorder.